Steven K. Hatchett's departure as Chief Product Officer of Nu Skin Enterprises, Inc. was reported, effective May 8, 2026; the filing names no successor. As of November 6, 2026, Nu Skin Enterprises, Inc. has reported 2 leadership change filings to the SEC under Item 5.02 of Form 8-K, from May 8, 2026 to May 29, 2026, naming 1 departure (Form 8-K, May 8, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Nu Skin Enterprises, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Nu Skin Enterprises, Inc. reported changes in 2 filings among its directors and officers to the SEC on Form 8-K, Item 5.02, from 2026-05-08 to 2026-05-29. They name 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Nu Skin Enterprises, Inc. files it.
Also on the record for Nu Skin Enterprises, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| May 14, 2026 | Stake report, Schedule 13G/A, by CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 4.45% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| February 12, 2026 | Stake report, Schedule 13G, by CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 5.37% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Nu Skin Enterprises, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Nu Skin Enterprises, Inc. and the records around it.
Nu Skin Enterprises, Inc. elsewhere on the record
Companies that share a holder
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC also filed stake reports on 12 other companies: HAIN CELESTIAL GROUP INC (Aug 2026), MEDIFAST INC (Aug 2026), Service Properties Trust (Aug 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Nu Skin Enterprises, Inc.
Get an email when Nu Skin Enterprises, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Nu Skin Enterprises, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Nu Skin Enterprises, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Nu Skin Enterprises, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-29 | Reported | not named in the filing | 8-K, 2026-05-29 | ||
| 2026-05-08 | Out | Chief Product Officer | 2026-05-08 | 8-K, 2026-05-08 |
Who leads Nu Skin Enterprises, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Product Officer: Steven K. Hatchett, departure reported, effective 2026-05-08 (filed 2026-05-08). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Nu Skin Enterprises, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Product Officer at Nu Skin Enterprises, Inc., with the record behind each one.
Find candidates like Chief Product Officer at Nu Skin Enterprises, Inc.Every change, in the filing's words
Reported
The termination date is extended to the tenth anniversary of the effective date of the Amended and Restated Plan, which is May 28, 2036.
- (e) On May 28, 2026, at the Nu Skin Enterprises, Inc. (the "Company") 2026 Annual Meeting of Stockholders (the "Annual Meeting"), the Company's stockholders approved and adopted the Company's Amended and Restated 2024 Omnibus Incentive Plan (the "Amended and Restated Plan" or the "Plan"), which previously had been approved by the Company's Board of Directors and its Compensation and Human Capital Committee subject to stockholder approval.
- The Amended and Restated Plan amends the prior version of the Plan primarily as follows: 1.
- The Plan increases the share authorization by 2,850,000 shares. 2.
- A more detailed summary of the Amended and Restated Plan can be found in the Company's proxy statement for the Annual Meeting filed with the U.S. Securities and Exchange Commission on April 3, 2026.
Departing: Steven K. Hatchett, Chief Product Officer, effective 2026-05-08
On May 6, 2026, Steven K. Hatchett notified the Company that, due to family health circumstances, he determined to resign from his position as Executive Vice President and Chief Product Officer, effective as of May 8, 2026.
- Mr. Hatchett has agreed to remain with the Company as a strategic product advisor with an annual salary of $147,478.
- The Company wishes Mr. Hatchett and his family well and extends its appreciation to him for his great contributions as Chief Product Officer.
Tools for this story
Each opens in a new tab, filled in for Nu Skin Enterprises, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.